Cirtran(CIRX)
$0.020.00 (0.00%)
CIRX
Cirtran financials statements
$0.02
At close:0.00 (0.00%)
Want to see CIRX full AI Analyst Report?
Cirtran (CIRX) Ratios
2 Followers
Cirtran Ratios
CIRX's free cash flow for Q2 2026 was $183.69K. For the 2026 fiscal year, CIRX's free cash flow was decreased by $-4.00 and operating cash flow was $183.69K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.09 | 0.06 | 0.07 | 0.04 | 0.03 |
| Quick Ratio | 0.05 | 0.02 | 0.02 | 0.02 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.03 | -0.10 | 0.86 | -0.03 | -0.01 |
| Operating Cash Flow Ratio | -0.05 | -0.00 | -0.00 | 0.00 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -2.64 | -0.09 | -0.14 | 0.30 | 0.52 |
| Net Current Asset Value | $ -25.36M | $ -24.66M | $ -22.10M | $ -42.38M | $ -40.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.37 | 2.19 | 1.74 | 1.58 | 2.20 |
| Debt-to-Equity Ratio | -0.14 | -0.14 | -0.15 | -0.08 | -0.08 |
| Debt-to-Capital Ratio | -0.16 | -0.16 | -0.17 | -0.08 | -0.09 |
| Long-Term Debt-to-Capital Ratio | -0.13 | -0.13 | -0.14 | -0.07 | -0.07 |
| Financial Leverage Ratio | -0.10 | -0.06 | -0.08 | -0.05 | -0.04 |
| Debt Service Coverage Ratio | -0.87 | -1.26 | 0.18 | -0.49 | -0.09 |
| Interest Coverage Ratio | 0.16 | -0.70 | -0.02 | -0.74 | -0.34 |
| Debt to Market Cap | 16.14 | 33.96 | 28.67 | 25.56 | 18.69 |
| Interest Debt Per Share | 0.53 | 0.84 | 0.81 | 0.78 | 0.80 |
| Net Debt to EBITDA | 12.39 | -1.90 | 14.52 | -5.59 | -25.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 49.27% | 64.67% | 62.28% | 59.49% | 64.96% |
| EBIT Margin | 8.78% | -135.47% | 13.44% | -34.22% | -5.41% |
| EBITDA Margin | 8.84% | -135.14% | 13.72% | -32.70% | -4.34% |
| Operating Profit Margin | -4.15% | -42.47% | -0.92% | -30.38% | -7.80% |
| Pretax Profit Margin | -17.53% | -196.43% | -34.14% | -75.48% | -28.68% |
| Net Profit Margin | -22.44% | -202.57% | 1255.35% | -78.44% | -21.46% |
| Continuous Operations Profit Margin | -17.53% | -190.70% | -33.61% | -78.44% | -28.68% |
| Net Income Per EBT | 128.00% | 103.12% | -3677.43% | 103.92% | 74.82% |
| EBT Per EBIT | 422.57% | 462.53% | 3698.46% | 248.47% | 367.77% |
| Return on Assets (ROA) | -27.91% | -171.43% | 1097.52% | -67.48% | -42.87% |
| Return on Equity (ROE) | 2.79% | 10.76% | -93.16% | 3.21% | 1.55% |
| Return on Capital Employed (ROCE) | 0.58% | 2.55% | 0.08% | 1.33% | 0.60% |
| Return on Invested Capital (ROIC) | 0.60% | 2.54% | 0.08% | 1.34% | 0.61% |
| Return on Tangible Assets | -27.91% | -171.43% | 1097.52% | -67.48% | -42.87% |
| Earnings Yield | -329.94% | -2657.20% | 18072.50% | -1090.81% | -366.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.55 | 50.58 | 75.04 | 27.35 | 13.77 |
| Payables Turnover | 10.61 | 0.60 | 0.97 | 0.30 | 0.53 |
| Inventory Turnover | 1.40 | 0.62 | 0.57 | 0.85 | 1.90 |
| Fixed Asset Turnover | 678.73 | 202.40 | 85.40 | 114.49 | 70.97 |
| Asset Turnover | 1.24 | 0.85 | 0.87 | 0.86 | 2.00 |
| Working Capital Turnover Ratio | -0.14 | -0.06 | -0.05 | -0.04 | -0.08 |
| Cash Conversion Cycle | 269.83 | -12.87 | 268.99 | -776.81 | -467.32 |
| Days of Sales Outstanding | 42.68 | 7.22 | 4.86 | 13.35 | 26.50 |
| Days of Inventory Outstanding | 261.53 | 587.32 | 638.82 | 427.60 | 191.67 |
| Days of Payables Outstanding | 34.39 | 607.41 | 374.70 | 1217.76 | 685.49 |
| Operating Cycle | 304.21 | 594.54 | 643.68 | 440.95 | 218.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.27 | -0.01 | -0.01 | 0.03 | 0.07 |
| Free Cash Flow Per Share | -0.27 | -0.01 | -0.02 | 0.03 | 0.07 |
| Dividend Paid and CapEx Coverage Ratio | -334543.50 | 0.00 | -8.63 | 0.00 | 90.69 |
| Capital Expenditure Coverage Ratio | -334543.50 | 0.00 | -8.63 | 0.00 | 90.69 |
| Operating Cash Flow Coverage Ratio | -0.39 | -0.01 | -0.02 | 0.05 | 0.11 |
| Operating Cash Flow to Sales Ratio | -0.43 | -0.04 | -0.04 | 0.09 | 0.12 |
| Free Cash Flow Yield | -629.28% | -46.89% | -72.17% | 128.85% | 198.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.31 | -0.04 | 0.01 | -0.09 | -0.27 |
| Price-to-Sales (P/S) Ratio | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 |
| Price-to-Book (P/B) Ratio | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.16 | -2.13 | -1.39 | 0.78 | 0.50 |
| Price-to-Operating Cash Flow Ratio | -0.16 | -2.13 | -1.55 | 0.78 | 0.50 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.00 | -0.00 | 0.01 |
| Enterprise Value Multiple | 13.16 | -1.95 | 15.02 | -5.81 | -26.74 |
| Enterprise Value | 3.64M | 3.43M | 3.33M | 3.27M | 3.39M |
| EV to EBITDA | 13.16 | -1.95 | 15.02 | -5.81 | -26.74 |
| EV to Sales | 1.16 | 2.64 | 2.06 | 1.90 | 1.16 |
| EV to Free Cash Flow | -2.72 | -73.90 | -41.11 | 20.50 | 9.95 |
| EV to Operating Cash Flow | -2.72 | -73.90 | -45.88 | 20.50 | 9.84 |
| Tangible Book Value Per Share | -5.08 | -4.93 | -4.40 | -8.51 | -8.29 |
| Shareholders’ Equity Per Share | -5.08 | -4.93 | -4.40 | -8.51 | -8.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.03 | 0.02 | -0.04 | 0.00 |
| Revenue Per Share | 0.63 | 0.26 | 0.33 | 0.35 | 0.60 |
| Net Income Per Share | -0.14 | -0.53 | 4.10 | -0.27 | -0.13 |
| Tax Burden | 1.28 | 1.03 | -36.77 | 1.04 | 0.75 |
| Interest Burden | -2.00 | 1.45 | -2.54 | 2.21 | 5.31 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.53 | 1.07 | 0.63 | 0.90 | 0.73 |
| Stock-Based Compensation to Revenue | 0.09 | 0.24 | 0.00 | 0.27 | 0.00 |
| Income Quality | 1.91 | 0.02 | -0.00 | -0.11 | -0.41 |
Currency in USD
